Pathophysiologic basis for normouricosuric uric acid nephrolithiasis
Khashayar Sakhaee(The University of Texas Southwestern Medical Center), Charles Y.C. Pak(Southwestern University), Orson W. Moe(Io Therapeutics (United States)), Beverley Adams‐Huet(Southwestern Medical Center)
Cited by 346
Related Papers
Global kidney health 2017 and beyond: a roadmap for closing gaps in care, research, and policy
|The Lancet|2017|923
Effect of Hydroxymethyl Glutaryl Coenzyme A Reductase Inhibitor Therapy on High Sensitive C-Reactive Protein Levels
|Circulation|2001|732
Hyperuricemia, Acute and Chronic Kidney Disease, Hypertension, and Cardiovascular Disease: Report of a Scientific Workshop Organized by the National Kidney Foundation
|American Journal of Kidney Diseases|2018|644
Association of urinary pH with body weight in nephrolithiasis
|Kidney International|2004|404
Renal Transport of Uric Acid: Evolving Concepts and Uncertainties
|Advances in Chronic Kidney Disease|2012|394